Listed

Kodiak Sciences Inc.

KODNasdaqCIK 1468748HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$66.8m, Q2 FY2026
Net income−$65.6m, Q2 FY2026
Kodiak Sciences Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m36.2Research and development, Q3 FY2023, three months to 2023-09-30$36.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0000950170-24-127059.Report this figure46.6Research and development, Q4 FY2023, three months to 2023-12-31$46.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001193125-26-134887. Derived: 12-month figure less the 9-month figure.Report this figure29.9Research and development, Q1 FY2024, three months to 2024-03-31$29.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0000950170-25-071523.Report this figure32.5Research and development, Q2 FY2024, three months to 2024-06-30$32.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-13, accession 0000950170-25-108033.Report this figure31.9Research and development, Q3 FY2024, three months to 2024-09-30$31.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figure31.8Research and development, Q4 FY2024, three months to 2024-12-31$31.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001193125-26-134887. Derived: 12-month figure less the 9-month figure.Report this figure43.6Research and development, Q1 FY2025, three months to 2025-03-31$43.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211951.Report this figure42.8Research and development, Q2 FY2025, three months to 2025-06-30$42.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure50.5Research and development, Q3 FY2025, three months to 2025-09-30$50.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figure45.5Research and development, Q4 FY2025, three months to 2025-12-31$45.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001193125-26-134887. Derived: 12-month figure less the 9-month figure.Report this figure48.5Research and development, Q1 FY2026, three months to 2026-03-31$48.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211951.Report this figure56.1Research and development, Q2 FY2026, three months to 2026-06-30$56.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure
Operating income$m(54.5)Operating income, Q3 FY2023, three months to 2023-09-30−$54.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0000950170-24-127059.Report this figure(63.4)Operating income, Q4 FY2023, three months to 2023-12-31−$63.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134887. Derived: 12-month figure less the 9-month figure.Report this figure(46.1)Operating income, Q1 FY2024, three months to 2024-03-31−$46.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0000950170-25-071523.Report this figure(48.0)Operating income, Q2 FY2024, three months to 2024-06-30−$48.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0000950170-25-108033.Report this figure(46.6)Operating income, Q3 FY2024, three months to 2024-09-30−$46.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figure(46.2)Operating income, Q4 FY2024, three months to 2024-12-31−$46.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134887. Derived: 12-month figure less the 9-month figure.Report this figure(59.1)Operating income, Q1 FY2025, three months to 2025-03-31−$59.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211951.Report this figure(55.5)Operating income, Q2 FY2025, three months to 2025-06-30−$55.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure(62.4)Operating income, Q3 FY2025, three months to 2025-09-30−$62.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figure(57.5)Operating income, Q4 FY2025, three months to 2025-12-31−$57.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134887. Derived: 12-month figure less the 9-month figure.Report this figure(59.8)Operating income, Q1 FY2026, three months to 2026-03-31−$59.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211951.Report this figure(66.8)Operating income, Q2 FY2026, three months to 2026-06-30−$66.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$5.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-14, accession 0000950170-24-127059.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-31, accession 0001193125-26-134887. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-15, accession 0000950170-24-060483.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-14, accession 0000950170-24-097010.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-14, accession 0000950170-24-127059.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-31, accession 0001193125-26-134887. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(50.0)Net income, Q3 FY2023, three months to 2023-09-30−$50.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0000950170-24-127059.Report this figure(59.5)Net income, Q4 FY2023, three months to 2023-12-31−$59.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134887. Derived: 12-month figure less the 9-month figure.Report this figure(43.0)Net income, Q1 FY2024, three months to 2024-03-31−$43.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figure(45.1)Net income, Q2 FY2024, three months to 2024-06-30−$45.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figure(43.9)Net income, Q3 FY2024, three months to 2024-09-30−$43.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figure(44.1)Net income, Q4 FY2024, three months to 2024-12-31−$44.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134887. Derived: 12-month figure less the 9-month figure.Report this figure(57.5)Net income, Q1 FY2025, three months to 2025-03-31−$57.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure(54.3)Net income, Q2 FY2025, three months to 2025-06-30−$54.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure(61.5)Net income, Q3 FY2025, three months to 2025-09-30−$61.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figure(56.7)Net income, Q4 FY2025, three months to 2025-12-31−$56.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134887. Derived: 12-month figure less the 9-month figure.Report this figure(58.2)Net income, Q1 FY2026, three months to 2026-03-31−$58.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure(65.6)Net income, Q2 FY2026, three months to 2026-06-30−$65.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure
Diluted EPS$ per share(0.95)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.95 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0000950170-24-127059.Report this figurenot reported(0.82)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0000950170-25-071523.Report this figure(0.86)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.86 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0000950170-25-108033.Report this figure(0.84)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.84 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figurenot reported(1.09)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-211951.Report this figure(1.03)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure(1.16)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figurenot reported(0.94)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.94 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-211951.Report this figure(1.05)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure
Basic EPS$ per share(0.95)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.95 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0000950170-24-127059.Report this figurenot reported(0.82)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.82 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0000950170-25-071523.Report this figure(0.86)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.86 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0000950170-25-108033.Report this figure(0.84)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.84 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figurenot reported(1.09)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-211951.Report this figure(1.03)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure(1.16)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figurenot reported(0.94)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.94 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-211951.Report this figure(1.05)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure

Balance sheet

Cash and equivalents$125.9m, Q2 FY2026
Shareholders' equity$61.1m, Q2 FY2026
Kodiak Sciences Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m346Cash and equivalents, Q3 FY2023, at 2023-09-30$345.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0000950170-24-127059.Report this figure286Cash and equivalents, FY2023, at 2023-12-31$285.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-31, accession 0001193125-26-134887.Report this figure246Cash and equivalents, Q1 FY2024, at 2024-03-31$245.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0000950170-25-071523.Report this figure219Cash and equivalents, Q2 FY2024, at 2024-06-30$219.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0000950170-25-108033.Report this figure198Cash and equivalents, Q3 FY2024, at 2024-09-30$197.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figure168Cash and equivalents, FY2024, at 2024-12-31$168.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-31, accession 0001193125-26-134887.Report this figure139Cash and equivalents, Q1 FY2025, at 2025-03-31$138.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-211951.Report this figure104Cash and equivalents, Q2 FY2025, at 2025-06-30$104.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure72.0Cash and equivalents, Q3 FY2025, at 2025-09-30$72.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figure210Cash and equivalents, FY2025, at 2025-12-31$209.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure170Cash and equivalents, Q1 FY2026, at 2026-03-31$169.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-211951.Report this figure126Cash and equivalents, Q2 FY2026, at 2026-06-30$125.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure
Current assets$m351Current assets, Q3 FY2023, at 2023-09-30$350.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0000950170-23-063767.Report this figure289Current assets, FY2023, at 2023-12-31$289.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-27, accession 0000950170-25-046098.Report this figure252Current assets, Q1 FY2024, at 2024-03-31$251.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0000950170-24-060483.Report this figure225Current assets, Q2 FY2024, at 2024-06-30$224.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0000950170-24-097010.Report this figure202Current assets, Q3 FY2024, at 2024-09-30$202.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-127059.Report this figure172Current assets, FY2024, at 2024-12-31$171.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-31, accession 0001193125-26-134887.Report this figure143Current assets, Q1 FY2025, at 2025-03-31$142.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0000950170-25-071523.Report this figure108Current assets, Q2 FY2025, at 2025-06-30$107.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0000950170-25-108033.Report this figure75.7Current assets, Q3 FY2025, at 2025-09-30$75.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figure215Current assets, FY2025, at 2025-12-31$214.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure175Current assets, Q1 FY2026, at 2026-03-31$175.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-211951.Report this figure131Current assets, Q2 FY2026, at 2026-06-30$131.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure
Total assets$m548Total assets, Q3 FY2023, at 2023-09-30$547.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0000950170-23-063767.Report this figure479Total assets, FY2023, at 2023-12-31$479.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-27, accession 0000950170-25-046098.Report this figure435Total assets, Q1 FY2024, at 2024-03-31$434.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0000950170-24-060483.Report this figure402Total assets, Q2 FY2024, at 2024-06-30$401.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0000950170-24-097010.Report this figure373Total assets, Q3 FY2024, at 2024-09-30$372.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0000950170-24-127059.Report this figure336Total assets, FY2024, at 2024-12-31$335.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-31, accession 0001193125-26-134887.Report this figure298Total assets, Q1 FY2025, at 2025-03-31$297.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0000950170-25-071523.Report this figure257Total assets, Q2 FY2025, at 2025-06-30$256.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0000950170-25-108033.Report this figure218Total assets, Q3 FY2025, at 2025-09-30$218.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figure352Total assets, FY2025, at 2025-12-31$351.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure306Total assets, Q1 FY2026, at 2026-03-31$306.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-211951.Report this figure257Total assets, Q2 FY2026, at 2026-06-30$256.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure
Current liabilities$m70.8Current liabilities, Q3 FY2023, at 2023-09-30$70.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0000950170-23-063767.Report this figure41.7Current liabilities, FY2023, at 2023-12-31$41.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-27, accession 0000950170-25-046098.Report this figure24.9Current liabilities, Q1 FY2024, at 2024-03-31$24.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0000950170-24-060483.Report this figure21.2Current liabilities, Q2 FY2024, at 2024-06-30$21.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0000950170-24-097010.Report this figure24.1Current liabilities, Q3 FY2024, at 2024-09-30$24.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-127059.Report this figure25.6Current liabilities, FY2024, at 2024-12-31$25.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-31, accession 0001193125-26-134887.Report this figure30.9Current liabilities, Q1 FY2025, at 2025-03-31$30.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0000950170-25-071523.Report this figure31.0Current liabilities, Q2 FY2025, at 2025-06-30$31.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0000950170-25-108033.Report this figure42.4Current liabilities, Q3 FY2025, at 2025-09-30$42.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figure45.5Current liabilities, FY2025, at 2025-12-31$45.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure49.6Current liabilities, Q1 FY2026, at 2026-03-31$49.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-211951.Report this figure52.8Current liabilities, Q2 FY2026, at 2026-06-30$52.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure
Total liabilities$m245Total liabilities, Q3 FY2023, at 2023-09-30$245.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0000950170-23-063767.Report this figure214Total liabilities, FY2023, at 2023-12-31$213.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-27, accession 0000950170-25-046098.Report this figure194Total liabilities, Q1 FY2024, at 2024-03-31$193.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0000950170-24-060483.Report this figure187Total liabilities, Q2 FY2024, at 2024-06-30$187.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0000950170-24-097010.Report this figure187Total liabilities, Q3 FY2024, at 2024-09-30$187.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0000950170-24-127059.Report this figure185Total liabilities, FY2024, at 2024-12-31$185.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-31, accession 0001193125-26-134887.Report this figure189Total liabilities, Q1 FY2025, at 2025-03-31$189.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0000950170-25-071523.Report this figure186Total liabilities, Q2 FY2025, at 2025-06-30$186.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0000950170-25-108033.Report this figure194Total liabilities, Q3 FY2025, at 2025-09-30$194.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figure194Total liabilities, FY2025, at 2025-12-31$194.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure194Total liabilities, Q1 FY2026, at 2026-03-31$193.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-211951.Report this figure196Total liabilities, Q2 FY2026, at 2026-06-30$195.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure
Shareholders' equity$m302Shareholders' equity, Q3 FY2023, at 2023-09-30$302.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0000950170-24-127059.Report this figure266Shareholders' equity, FY2023, at 2023-12-31$265.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-31, accession 0001193125-26-134887.Report this figure241Shareholders' equity, Q1 FY2024, at 2024-03-31$241.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figure215Shareholders' equity, Q2 FY2024, at 2024-06-30$214.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figure185Shareholders' equity, Q3 FY2024, at 2024-09-30$185.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figure150Shareholders' equity, FY2024, at 2024-12-31$150.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure109Shareholders' equity, Q1 FY2025, at 2025-03-31$108.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure70.3Shareholders' equity, Q2 FY2025, at 2025-06-30$70.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure23.7Shareholders' equity, Q3 FY2025, at 2025-09-30$23.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figure157Shareholders' equity, FY2025, at 2025-12-31$157.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure112Shareholders' equity, Q1 FY2026, at 2026-03-31$112.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure61.1Shareholders' equity, Q2 FY2026, at 2026-06-30$61.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure

Cash flow

Operating cash flow−$46.2m, Q2 FY2026
Capital expenditure$352.0k, Q2 FY2026
Kodiak Sciences Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(32.8)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$32.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0000950170-24-127059. Derived: 9-month figure less the 6-month figure.Report this figure(32.2)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$32.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001193125-26-134887. Derived: 12-month figure less the 9-month figure.Report this figure(39.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$39.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0000950170-25-071523.Report this figure(26.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$26.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0000950170-25-108033. Derived: 6-month figure less the 3-month figure.Report this figure(21.2)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$21.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-280183. Derived: 9-month figure less the 6-month figure.Report this figure(30.1)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$30.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001193125-26-134887. Derived: 12-month figure less the 9-month figure.Report this figure(29.1)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$29.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-211951.Report this figure(34.7)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$34.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349251. Derived: 6-month figure less the 3-month figure.Report this figure(32.9)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$32.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-280183. Derived: 9-month figure less the 6-month figure.Report this figure(39.4)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$39.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001193125-26-134887. Derived: 12-month figure less the 9-month figure.Report this figure(40.0)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$40.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-211951.Report this figure(46.2)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$46.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349251. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.2Capital expenditure, Q3 FY2023, three months to 2023-09-30$226.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0000950170-24-127059. Derived: 9-month figure less the 6-month figure.Report this figure27.5Capital expenditure, Q4 FY2023, three months to 2023-12-31$27.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001193125-26-134887. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$22.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0000950170-25-071523.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$49.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-13, accession 0000950170-25-108033. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$180.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001193125-25-280183. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$124.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001193125-26-134887. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2025, three months to 2025-03-31$270.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-211951.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$133.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-349251. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$60.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001193125-25-280183. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$43.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001193125-26-134887. Derived: 12-month figure less the 9-month figure.Report this figure0.9Capital expenditure, Q1 FY2026, three months to 2026-03-31$942.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-211951.Report this figure0.4Capital expenditure, Q2 FY2026, three months to 2026-06-30$352.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-349251. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)62.63m, Q2 FY2026
Kodiak Sciences Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares52.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3052,288,257 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0000950170-23-063767.Report this figure52.3Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3152,337,603 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0000950170-24-060483.Report this figure52.4Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3052,378,729 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0000950170-24-097010.Report this figure52.5Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3052,455,620 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0000950170-24-127059.Report this figure52.5Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3152,510,460 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0000950170-25-071523.Report this figure52.6Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3052,554,215 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-13, accession 0000950170-25-108033.Report this figure52.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3052,616,183 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figure52.7Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3152,746,318 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-211951.Report this figure52.8Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3052,779,162 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure52.9Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3052,859,308 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001193125-25-280183.Report this figure61.9Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3161,859,485 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-211951.Report this figure62.6Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3062,628,596 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure

Shares outstanding: 62.85mShares outstanding, period not labelled, at 2026-08-0662,849,457 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349251.Report this figure at Aug 6, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. Listed shows no prices and gives no investment advice.